首页> 外文期刊>臨床血液 >Mucoepidermoid carcinoma of the parotid gland as a secondary malignancy developed ten years after chemotherapy for childhood acute lymphoblastic leukemia
【24h】

Mucoepidermoid carcinoma of the parotid gland as a secondary malignancy developed ten years after chemotherapy for childhood acute lymphoblastic leukemia

机译:腮腺黏液表皮样样癌为继发性恶性肿瘤,在儿童急性淋巴细胞白血病化疗后十年后发展

获取原文
获取原文并翻译 | 示例
           

摘要

We report on a case of mucoepidermoid carcinoma of the parotid gland following treatment of acute lymphoblastic leukemia (ALL) in childhood. The female patient was diagnosed as having T-cell ALL at the age of 13 years. Treatment included multidrug chemotherapy and prophylactic 18 Gy cranial irradiation. She developed low-grade mucoepidermoid carcinoma of the right parotid gland at the age of 24 years, the most probable cause of the secondary malignancy being radiation. In a literature review of mucoepidermoid carcinoma following ALL, 11 out of 14 cases received radiation therapy for the initial treatment of ALL, but 3 cases had no radiation therapy. The parotid gland carcinoma as a secondary malignancy following ALL in childhood is rare, but it highlights the need for concern about the secondary malignancy in patients with painless parotid swelling after chemoradiotherapy.
机译:我们报告了儿童急性淋巴细胞白血病(ALL)治疗后腮腺黏液表皮样癌的病例。该女性患者在13岁时被诊断患有T细胞ALL。治疗包括多药化疗和预防性18 Gy颅骨照射。她在24岁时出现了右腮腺低度粘液表皮样癌,继发性恶性肿瘤最可能的原因是放射。在ALL后的粘液表皮样癌的文献综述中,有14例中有11例接受了放射疗法作为ALL的初始治疗,但3例没有进行放射疗法。腮腺癌在儿童期继发于ALL的继发性恶性肿瘤很少见,但这突显了放化疗后腮腺无痛患者的继发性恶性肿瘤的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号